“By harnessing the power of soundwaves, we can stimulate the body’s natural healing mechanisms and help men regain their confidence in the bedroom,” says Dr. Houman.

LOS ANGELES (PRWEB)
June 08, 2023

Dr. Justin Houman, a leading urologist based in Los Angeles, is thrilled to announce the integration of Shockwave Therapy for the treatment of Erectile Dysfunction (ED). With this cutting-edge treatment, Dr. Houman aims to provide patients with a highly effective, non-invasive solution to overcome the challenges of ED and regain their sexual confidence.

Erectile Dysfunction affects millions of men worldwide, causing emotional distress and straining relationships. Dr. Justin Houman understands the impact that ED can have on a man’s self-esteem and overall quality of life. Through his dedication to staying at the forefront of medical advancements, Dr. Houman has introduced Shockwave Therapy as a breakthrough treatment option for his patients.

Shockwave Therapy is a non-surgical procedure that utilizes low-intensity acoustic waves to stimulate blood flow and encourage tissue regeneration in the penile area. By enhancing blood circulation and promoting the growth of new blood vessels, Shockwave Therapy addresses the root causes of ED rather than merely alleviating symptoms. This innovative therapy has shown promising results in numerous clinical studies, demonstrating its efficacy in restoring erectile function.

Dr. Justin Houman possesses extensive experience in the field of urology and has a reputation for providing personalized and compassionate care to his patients. By incorporating Shockwave Therapy into his comprehensive range of treatment options, he is empowering men to take control of their sexual health and achieve satisfying, natural erections without the need for invasive surgeries or medication.

“I am thrilled to offer Shockwave Therapy as a safe and effective solution for men struggling with Erectile Dysfunction,” said Dr. Houman. “By harnessing the power of soundwaves, we can stimulate the body’s natural healing mechanisms and help men regain their confidence in the bedroom. This treatment option has the potential to revolutionize the way we approach ED and significantly improve the lives of countless individuals.”

Dr. Houman and his team provide a supportive and discreet environment where patients can openly discuss their concerns and receive tailored treatment plans. With his expertise and the integration of Shockwave Therapy, Dr. Houman is committed to helping his patients achieve optimal results and restore their sexual vitality.

More about Dr. Justin Houman:

Dr. Justin Houman earned his medical doctorate degree at the University of Rochester School of Medicine. He completed his general surgery internship and urology residency at Cedars-Sinai Medical Center in LA. Dr. Houman continued his training at UCLA Medical Center, having completed a fellowship in the highly specialized field of male reproductive medicine and surgery. He is a member of the American Urological Association, Sexual Medicine Society of North America, International Society of Sexual Medicine and Los Angeles Urologic Society. He is fluent in English, Spanish and Farsi. Dr. Justin Houman’s clinic is located at 8635 W 3rd St, Suite 1W in Los Angeles, CA.

To find out more information or schedule an appointment with Dr. Houman, please visit http://www.houmanmd.com or call 310-854-9898.

Share article on social media or email:

RFT Releases Enterprise 7.2 with Epic and Cerner integration. HL7 ADT Interoperability

“The launch of Enterprise Software 7.2 marks a significant milestone for RF Technologies and the hospitals that rely on our life safety solutions,” said Bob Metzler, RFT, VP of Product Management & Marketing.

BROOKFIELD, Wis. (PRWEB)
June 08, 2023

RF Technologies (RFT®), a leading provider of cutting-edge life-safety solutions in hospital settings, is pleased to announce the release of Enterprise Software 7.2. This highly anticipated update brings a multitude of powerful features and enhancements, further solidifying RF Technologies’ position as an industry leader.

Built to the Health Level 7 (HL7®) admit, discharge and transfer (ADT) interoperability standard, Enterprise 7.2 ensures important and crucial interoperability with electronic medical record (EMR) and electronic health record (EHR) standards.

The Enterprise Software 7.2 release is a testament to RF Technologies’ commitment to delivering innovative solutions and software that drive efficiency, enhance security, and streamline operations for health care systems of all sizes. This update introduces an array of benefits that empower health care organizations to excel in today’s fast-paced, person-centered care landscape.

One of the standout features of Enterprise Software 7.2 is its enhanced HL7 ADT message initiation through EMR integration capabilities. With advanced interoperability, Safe Place Enterprise Software seamlessly integrates with any medical records system, including but not limited to Epic and Cerner. RF Technologies understands the paramount importance of safeguarding data through automation in an increasingly interconnected world.

“The launch of Enterprise Software 7.2 marks a significant milestone for RF Technologies and the hospitals that rely on our life safety solutions,” said Bob Metzler, RFT, VP of Product Management & Marketing, “with this release, RFT positions Safe Place as a leader in interoperability for the infant protection market.”

The Enterprise Software 7.2 release helps save time and reduce errors when admitting an infant. In addition, RFT’s Enterprise Software 7.2 can fully automate the admission of the infant, unlike competitive systems which can only arrive the mother.

The latest update to Enterprise Software features our intuitive user interface “designed by nurses for nurses” allowing for seamless navigation, enabling users to effortlessly access and manage critical safety systems and alarms. Furthermore, the software’s intelligent automation capabilities reduce manual tasks, freeing up valuable time for employees to focus on providing the highest level of care.

RF Technologies is renowned for its exceptional customer support and commitment to ongoing improvement. With the release of Enterprise Software 7.2, customers can expect regular updates and new features as part of RF Technologies’ continuous enhancement program, ensuring their investment remains future-proof and relevant in a rapidly changing life safety landscape.

For more information about RF Technologies and Enterprise Software 7.2, please visit https://www.rft.com/infant-security/ or contact our customer care team at customercare@rft.com.

For questions or inquiries, please contact the RFT marketing department at marcomm@rft.com.

About RF Technologies:

RFT is a turn-key manufacturer and provider of life safety solutions for the senior living, healthcare, education, and hospitality markets. With 11,000+ installations since their founding in 1987, RFT is a collaborative partner in designing custom-configured solutions that meet each customer’s needs and reduce their liabilities. The RFT family of solutions includes CODE ALERT® nurse call, fall detection, and wander management, SAFE PLACE® patient, staff, and asset protection, HELP ALERT® staff duress, and SENSATEC® fall management products.

Share article on social media or email:

Launch Hydrate in four refreshing flavors with Cognizin Citicoline

“We wanted to enter the sports drinks market with a brand that was winning from day one,” commented Dillon Houstoun, VP of Finance and Operations, Launch Hydrate .

NEW YORK (PRWEB)
June 08, 2023

Launch Hydrate™ recently announced their game-changing sports drinks featuring Cognizin® Citicoline. With a unique blend of electrolytes and essential vitamins and minerals, athletes will be able to hydrate quickly, focus better and recover faster.

According to Fortune Business Insights, the growing inclination for physically active and fitness-related activities among millennials, primarily among athletes, increasing purchasing power, and willingness to pay for healthier alternatives are key factors accelerating the demand for sports beverage products. In addition, sports beverages/drinks have several benefits, including minimizing dehydration and electrolytes to replace sweat and maintain electrolyte balance in the human body.

“We wanted to enter the sports drinks market with a brand that was winning from day one,” commented Dillon Houstoun, VP of Finance and Operations, Launch Hydrate . “That’s why we chose Cognizin®, because it sets us apart from other brands in the sector, with extensive research supporting our focus and attention claims. It’s a win, win.” Launch Hydrate™ is available in four natural flavors, Fruit Punch, Orange, Tropical and Lemon Strawberry. Each 16oz bottle delivers on Focus, Hydration and Recovery with 1200mg electrolytes, 125mg Cognizin®, and 90 calories.

“The United States Sports Drink Market size was valued at USD 6.50 billion in 2021 and is projected to grow from USD 6.77 billion in 2022 to USD 9.38 billion by 2029, according to Fortune Business Insights,“ says Karen Todd, MBA, RD, Vice President of Global Brand Marketing, Kyowa Hakko USA, Inc. “This presents many opportunities for Cognizin® and brands like Launch Hydrate, who have chosen to use our highly researched branded ingredient in their new line. Savvy brands understand the value of using a branded ingredient that can back claims with science.”

To learn more about Cognizin® Citicoline, please visit: https://cognizin.com

To purchase Launch Hydrate, please visit: https://www.launchhydrate.com

About Cognizin® Citicoline:

Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health. Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and recall. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, ultra-pure, and allergen-free. For more information on Cognizin®, visit Cognizin.com.

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, Eyemuse™ Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.

Media Contacts:

Giselle Chollett

giselle@adinnyc.com

917.386.7116.

Share article on social media or email:

TWERGO line up featuring TWERGO, TWERGO Xtreme and TWERGO Lite

Worker safety is a priority in our product design, and, as a result, our industrial casters move more with lower push forces required.

ALBION, Mich. (PRWEB)
June 08, 2023

Caster Concepts Inc., a global leader in the design and production of heavy-duty industrial casters, announces the expansion of its popular TWERGO® caster product line.

Designed to reduce strain injuries, Caster Concepts’ TWERGO® uses a unique dumbbell design to minimize caster wheel friction, reducing the force required to push or pull materials or completed manufacturing assemblies by up to 50 percent compared to traditional industrial caster designs.

Of all the factors that affect worker well-being in industrial manufacturing environments, ergonomic casters have become a crucial part of the safety equation. The amount of push force needed to move, turn and maneuver heavy duty carts and dollies can be reduced by using TWERGO casters that feature independently rotating wheels. The use of polyurethane wheels ensures even greater safety and longer caster life, lowering total cost of ownership for manufacturers.

“In today’s manufacturing environment, with staffing shortages at an all-time high and fewer people on production lines, the risk of OSHA recordable injuries is greater than ever,” said Doug Backinger, vice president of sales at Caster Concepts. “Worker safety is a priority in our product design, and, as a result, our industrial casters move more with lower push forces required.”

Caster Concepts will be exhibiting TWERGO® at the Voluntary Protection Programs Participants’ Association (VPPPA) Region V conference in South Bend, Ind. June 12 – 15 at booth 38.

• 
  TWERGO is the original ergonomic caster wheel. Not only can TWERGO® handle heavy loads, but it also reduces the amount of energy needed to move them, making TWERGO® the ideal wheel for heavier manual and powered applications.
• TWERGO Lite, The single 2” wide wheel version of our extraordinary TWERGO® wheels, utilizes the same patented face design to reduce initial and continuous push force. It is designed to replace standard caster wheels by adding significant ergonomic benefits, without significantly increasing the price.
• TWERGO XTREME, designed to move more weight without compromising safety, uses a unique barbell design and tapered tread to minimize caster wheel friction, reducing the force required to push or pull materials or completed manufacturing assemblies.

###

About Caster Concepts

Based in Albion MI, Caster Concepts designs and builds industrial heavy-duty casters and wheels for virtually any application. Companies rely on Caster Concepts to help them increase productivity and reduce the risk of worker injury in heavy-duty material handling applications. Our high-capacity casters feature load ratings that range from below 3000 pounds to over 100,000 pounds. Caster Concepts is ISO 9001-2015 certified and offers one of the industry’s shortest lead times, making it the premier choice for many industries. The company was awarded the 2022 Corporate Impact Award by the state of Michigan. Visit CasterConcepts.com

Share article on social media or email:

Forcura and Homecare Homebase Elevate Technology Partnership

“This expanded relationship will ensure HCHB clients have access to some of the most advanced home-based care workflow technology on the market, helping us solve key challenges and deliver tangible outcomes for providers across the country.”

DALLAS (PRWEB)
June 08, 2023

Forcura, a healthcare workflow management company, and Homecare Homebase (HCHB), the nation’s leading software for home-based care, today announced an expanded relationship expressly designed to solve some of the home-based care industry’s most pressing challenges. Through the evolved partnership, which began in 2018, Forcura and HCHB will help providers better accept patients into care, maximize efficiencies and strengthen their market positions.

The two companies are collaborating to ensure that Forcura’s newly enhanced referral management solution, available to the general market this July, is fully integrated with the patient chart in HCHB. Most notably, the solution will act as a referral hub, featuring functionality that enables clients to manage all referrals in one place regardless of referral source and will allow key patient referral data to automatically populate in both Forcura and HCHB systems.

This added functionality, powered by artificial intelligence and machine learning, will help to streamline care transitions for patients and provide clients increased visibility, faster processing and smarter insights on their business performance and referral partner value.

“From the start of our partnership in 2018, Forcura has shared a vision with HCHB on the role of technology and its ability to empower better patient care,” said Annie Erstling, Forcura’s chief operating officer. “As we continuously innovate the Forcura platform, our coordination with HCHB ensures that our mutual clients have the best possible experience with their technology – and have more time to focus on their patients.”

Since Forcura first became a partner of HCHB, the two companies have delivered significant impact to home-based care. Each month, Forcura’s platform, integrated with HCHB, helps more than half a million patients receive efficient, impactful care.

“Over the past five years, Forcura has served as a strong and collaborative partner that aligns with our goals of helping practices do business faster and smarter to ultimately enhance patient care,” said Scott Pattillo, CSO at HCHB. “This expanded relationship will ensure HCHB clients have access to some of the most advanced home-based care workflow technology on the market, helping us solve key challenges and deliver tangible outcomes for providers across the country.”

For more information on the Forcura-HCHB partnership, visit https://www.forcura.com/hchb-partner-.

About Homecare Homebase, LLC

Homecare Homebase is a Dallas-based software leader offering hosted, cloud-based solutions to streamline operations, simplify compliance and boost clinical and financial outcomes for home-based care agencies. Our customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting, and improved revenue cycle management. Founded by industry veterans in 1999, HCHB empowers over 200,000 users to service more than 800,000 patients daily, resulting in over one hundred million visits per year. The company is part of the Hearst Health network. For more information visit http://www.hchb.com or call us toll-free at 1- 866-535-HCHB (4242).

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

About Forcura

Forcura, a healthcare workflow management company headquartered in Jacksonville, Florida, facilitates continuity of care and improves business performance for providers via its automated workflow, collaboration and analytics SaaS solutions. The company is deeply committed to empowering better patient care and elevating the role of post-acute in the broader healthcare continuum. The company is a KLAS® rated technology vendor, is a certified Great Place to Work™ employer, and has ranked for the sixth consecutive year on the Inc. 5000. For more information visit forcura.com, call 800-378-0596 or follow Forcura on LinkedIn.

Media Contacts

Homecare Homebase:

Liz LeGrande

llegrande@hchb.com

Forcura:

Tyler Holder

tholder@highreason.com

904.645.6200

Share article on social media or email:

MCG will host a payer-provider panel discussion at AHIP 2023 in Portland, Oregon.

Regence, MultiCare Connected Care, and MCG were the first members of the HL7® Da Vinci Project to complete a scalable, end-to-end automation workflow for prior auth.

SEATTLE, Wash. (PRWEB)
June 08, 2023

MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces its Associate Vice President of Technology and Interoperability, Rajesh Godavarthi, will host a panel of payer and provider technology leaders at the AHIP 2023 conference. The panel session titled, “Prior Auth Automation: Insights from Implementing EHR-based Authorizations” will take place on Tuesday, June 13, 2023, from 12:15 pm to 12:45 pm Pacific Time. The panelists will share their insights on automating prior authorization workflows including the potential challenges and success metrics.

Panelists participating in the 30-minute session will include:

• 
  Rena Cardenas, Associate Vice President of Financial Clearance, MultiCare Health System
• Holly D’Amico, RN, BSN, MBA, FABC, Vice President, Clinical Services Engagement & Education, Highmark
• Heidi Kriz, MPH, RD, Director of Medical Policy and Medical Management; PA Transformation Lead, Regence
• Rajesh Godavarthi, Associate Vice President of Technology and Interoperability, MCG Health

Following the December 2022 release of the Proposed Rule on Advancing Interoperability and Improving Prior Authorization Processes from the Centers for Medicare & Medicaid Services (CMS), many health plans and hospitals are preparing for the technological transformation that will be required to automate prior authorizations.

Regence, MultiCare Connected Care, and MCG were the first members of the HL7® Da Vinci Project to complete a scalable, end-to-end automation workflow for prior auth using the HL7 Fast Healthcare Interoperability Resources (FHIR®) standard with the HL7 Da Vinci Project implementation guides (IGs). In May 2023, the three organizations were recognized by KLAS with a Points of Light award for their breakthrough work.

The AHIP 2023 conference takes place in Portland, Oregon, at the Oregon Convention Center, from June 13-15, 2023. More information is available about this event here: https://www.ahip.org/conferences/ahip-2023

###

About Regence

Regence serves more than 3.4 million people through its Regence health plans in Idaho, Oregon, Utah and Washington. Each Regence health plan is a nonprofit independent licensee of the Blue Cross and Blue Shield Association. Regence is part of a family of companies dedicated to transforming health care by delivering innovative products and services that change the way consumers nationwide experience health care. For more information, please visit regence.com.

About MultiCare

MultiCare Health System is a not-for-profit health care organization with 12 hospitals and more than 22,000 team members. We are committed to achieving our mission of a healing and a healthy future for all and delivering world-class health outcomes and exceptional experience.

As the largest community-based, locally governed health system in Washington state, our comprehensive system of health includes numerous primary care, urgent care and dedicated specialty services. For more information, visit MultiCare.org or follow us on Twitter, Facebook, Instagram.

About MCG Health

MCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG’s artificial intelligence and technology, infused with clinical expertise, enable its clients to prioritize and simplify their work. MCG’s world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

Share article on social media or email:

Achieving HITRUST Risk-based, 2-Year Certification showcases Prochant’s commitment to strong cybersecurity and data protection in the home-based care industry.

CHARLOTTE, N.C. (PRWEB)
June 08, 2023

Prochant, the only AI-driven reimbursement service for home-based care, today announced that it has earned the HITRUST certifications for its IT Infrastructure, Prochant Pulse (Connect Portal), Prochant Operations, and Data Center hosted at Microsoft Azure. The HITRUST Risk-based, 2-Year Certified status demonstrates that Prochant’s IT Infrastructure and Data Center have met demanding regulatory compliance and industry-defined requirements and are appropriately managing risk.

This achievement places Prochant in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

“Prochant proudly delivers best-in-class results when it comes to technology-driven healthcare reimbursement. The HITRUST Certification will allow Prochant to safely remain focused on finding quality solutions to common problems,” said Mathew Mammen, CEO of Prochant. “We are pleased to demonstrate to our customers the highest standards for data protection and information security.”

“The HITRUST Assurance Program is rigorous and reliable because of the comprehensiveness of control requirements, depth of review, and consistency of oversight,” said Bimal Sheth, Executive Vice President of Standards Development & Assurance Operations at HITRUST. “HITRUST Risk-based, 2-Year (r2) Certification demonstrates Prochant is taking the most proactive approach to cybersecurity, data protection, and risk management.”

ABOUT PROCHANT

Prochant is the only AI-driven reimbursement service provider in the home-based care industry. We deliver focused revenue cycle management (RCM) solutions to healthcare providers with 7 wholly-owned global delivery centers. Our expertise lies in providing end-to-end RCM for home-based care, infusion, and specialty pharmacies, consistently delivering exceptional results to some of the leading healthcare providers in the country. We harness specialized automation technology and deep industry knowledge to streamline the time-consuming and expensive reimbursement process. As a result, we help healthcare providers accelerate their collections, increase revenue, and reduce operational costs while managing risk. Prochant is HITRUST certified, the gold standard for HIPAA security. For more information, please visit prochant.com.

Share article on social media or email:

Participants experienced hands-on learning opportunities at the 2023 SAWC Spring | WHS | DLS. The meeting was one of HMP Global’s record-breaking spring events.

MALVERN, Pa. (PRWEB)
June 08, 2023

HMP Global, the leading omnichannel healthcare events and education company, saw record-breaking attendance, abstract submissions, and corporate support for its major spring 2023 meetings, signaling a strong return to in-person events and reaching pre-pandemic participation levels.

The mix of industry-leading, established meetings and new offerings this spring include Rx and Illicit Drug Summit and Psych Congress NP Institute held in April; the Symposium on Advanced Wound Care (SAWC) Spring | WHS | DLS and Senior Living Executive Conference, held in May, and Psych Congress Elevate and West Coast Symposium which took place in early June. Combined, the meetings drew more than 12,000 clinicians, researchers, exhibitors and other supporters for world-class educational and networking opportunities.

“Our communities were hungry for the chance to meet in person after the COVID-19 lockdowns and converting conferences to a virtual format for two years,” said Jeff Hennessy, Chairman and CEO, HMP Global. “There is great value in bringing people together to collaborate, engage, and gain strategies and best practices that ultimately improve care for patients around the world. It is exciting to see our meetings return to pre-pandemic attendance levels at this scale, and an honor to know that clinicians continue to choose HMP Global as their trusted source for continuing education.”

Overall, HMP Global’s full slate of meetings for 2023 is experiencing an across-the-board surge in the number of research abstracts submitted for presentation. So far this year, multiple conferences (including SAWC Spring | WHS | DLS) have received record-breaking numbers of abstract submissions, and the upcoming World Congress on Gastrointestinal Cancer, to be held June 28 – July 1 in Barcelona, also broke records for its 500-plus abstract submissions received.

“Many clinical trials require in-person visits to clinics, and this was largely halted during the pandemic,” said Randy Robbin, president, HMP Education, the medical education arm of HMP Global. “Now, research is proceeding as normal again and the work that was paused during the pandemic is concluding. We are seeing some exciting, practice-changing research results presented at our meetings this year. This provides a golden opportunity for clinicians to learn and grow professionally.”

The newest addition to HMP Global’s Psych Congress portfolio of events, the Psych Congress NP Institute, held its inaugural meeting in April in Boston. It was the most successful event launch in company history, breaking records for first-year attendance with more than 800 nurse practitioners, corporate sponsors, and supporters participating. Led by the world-class experts of Psych Congress, the event featured psychopharmacology education, deep dives into foundational principles, and terminology on treatment, disease, and medication classes.

“The NP Institute was an awesome experience,” said attendee Jordan Madden, APRN, PrairieCare Medical Group. “I’m in my first year of practice and I learned so much great information that I can immediately implement into my practice.”

HMP Global’s 2023 Rx Summit, America’s largest meeting focused on the drug misuse and overdose crisis, drew more than 3,500 participants “from federal to family” to the Georgia World Congress Center in Atlanta in April. At this meeting, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), announced from the main stage that the Biden-Harris administration officially designated fentanyl adulterated or associated with xylazine as an emerging threat to the United States. It was the first time this designation authority was used since it passed congress in 2018.

“Rx Summit was a great opportunity to meet people and network,” said Guanhui Chen, a post-graduate year 1 pharmacy resident and a presenter at Rx Summit. “This is the biggest conference I have ever attended, and our session on xylazine was very well received. People approached us afterward and asked questions for 45 minutes. … It was an honor to be here.”

While SAWC Spring’s partnership with the Wound Healing Society (WHS) is a long-standing one, 2023 was the first year the meeting also co-located with the Diabetic Limb Salvage (DLS) conference. This year’s meeting drew nearly 3,000 clinicians, faculty presenters, researchers, and supporters including 165 exhibiting companies and sponsors.

More than 500 abstracts were submitted to SAWC Spring | WHS | DLS, and 450 posters displayed late-breaking wound care research, new advances, strategies, and techniques to improve care and outcomes for patients. The meeting is dedicated to the research, management, treatment, and prevention of wounds; and through its partnership with DLS, this year’s event featured more limb salvage-focused topics in the educational program.

In its second year organizing the Senior Living Executive Conference, the official meeting of Argentum, HMP Global reported more than 2,000 participants and nearly 300 sponsors at its 2023 meeting in New Orleans. The Senior Living Executive Conference educational program focused on the latest policy developments, emerging issues impacting seniors and senior care facilities, and updates from experts on what the future holds for the industry.

“I’d highly recommend the Senior Living Executive Conference to anyone who wants to learn more about the senior living industry, network with peers, create relationships, and to move the industry forward,” said attendee Christy Van Der Westhuizen, SVP of Sales and Marketing, Legend Senior Living.

While the record participation levels are expected to continue at HMP Global’s in-person meetings for the remainder of 2023, the company also continues a robust offering of virtual meetings across a range of therapeutic areas. The virtual programs ensure affordable, accessible options for clinicians to obtain continuing education credits and further their professional growth and development.

To view the full portfolio of events, and to register for upcoming meetings, visit hmpglobal.com.portfolio.

ABOUT HMP GLOBAL 

HMP Global is the force behind Healthcare Made Practical — and is an omnichannel leader in healthcare content, events, and education, with a mission to improve patient care. The company produces accredited medical education events — in person and online via its proprietary VRTX Virtual platform — and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include the HMP Global Learning Network, healthcare’s most comprehensive source for news and information; Psych Congress, the largest independent mental health meeting in the U.S.; the Evolution of Psychotherapy, the world’s largest independent educational event for mental health professionals; the Leipzig Interventional Course (LINC), the leading, global gathering for interdisciplinary cardiovascular specialists; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

Student entrepreneurs engaging with each other in Tangen Hall, the home of Venture Lab and innovative student programs such as those supported by the Wolpows and The Arbour Way Foundation.

PHILADELPHIA (PRWEB)
June 08, 2023

Penn President Liz Magill and Wharton Dean Erika James are delighted to announce a $10 million gift to establish the Robin S. Wolpow, PAR’14 and Marc B. Wolpow, W’80, PAR’14 Fund for Healthcare Entrepreneurship at Venture Lab, the center for student entrepreneurship at the University of Pennsylvania. The Wolpows’ landmark gift, facilitated through the Arbour Way Foundation (“AWF”), will create vibrant programming focused on healthcare innovation and co-curricular learning and collaboration across the University of Pennsylvania.

“We are extraordinarily grateful to Robin and Marc Wolpow for sharing in Penn’s goal to ignite innovation across disciplines,” said President Magill. “Their visionary gift will provide the resources for students and faculty to develop, test, and scale more of their innovative ideas to have a long-lasting impact on healthcare. It will spur the launch of startups that will make a meaningful difference in the lives of patients and the broader community.”

The Wolpows’ commitment will establish and enhance connections across Penn to nurture student opportunities in healthcare entrepreneurship. With the Wolpows’ gift, Venture Lab will invite seasoned executives with experience in entrepreneurship to lead a healthcare vertical and provide invaluable insights to students. It will create a launchpad for student exploration through events, workshops, and internships—as well as awards and prizes supporting pre-seed startup development and discovery costs. An incubator and accelerator will engage Penn faculty and alumni experts and support student ventures in the healthcare space. The Wolpows’ gift will also fund case studies, research, a dedicated course, and an acceleration lab enabling students to examine alumni ventures and undertake consulting projects.

“I am deeply grateful for Robin and Marc’s devotion to expanding upon the Venture Lab ecosystem through healthcare entrepreneurship,” said Dean Erika James. “Venture Lab is a true destination for incubating and launching startups, providing Wharton and Penn students with the tools and the support they need to bring their ideas to fruition. The Wolpows’ philanthropic vision and involvement will match the entrepreneurial ambitions of students, bringing them together with one another as well as alumni and faculty leaders to tackle problems and create imperative solutions in healthcare.”

This leadership donation from the Wolpows coincides with their establishment of The Arbour Way Foundation, which supports health equity, educational opportunity, reproductive rights, and environmental defense. While Marc Wolpow earned his undergraduate degree from the Wharton School in 1980, he started his Penn education as a student of Arts and Sciences, with the intention of studying medicine. Wolpow went on to lead a purposeful career in finance and private equity, and remained strongly interested in healthcare.

The Wolpows have been dedicated champions of healthcare and the arts, as well as loyal and committed sponsors of Wharton and Penn. The Wolpows are joined in their support of Penn by their daughter and Penn alumna, Nina W. Rosborough, C’14, who currently serves on the Advisory Board for Kelly Writers House.

“Student entrepreneurs at Wharton and Penn possess unparalleled drive, enthusiasm, and creativity,” said Lori Rosenkopf, Vice Dean of Entrepreneurship, Simon and Midge Palley Professor, and Wharton Faculty Director at Venture Lab. “I am thrilled to partner with the Wolpows in offering these new opportunities to Venture Lab’s innovators. The healthcare space is one that is ripe for disruption, and I know we will see impactful businesses, products, and ideas launched in the coming years.” Vice Dean Rosenkopf continued, “The Wolpows have extended their generosity of time and insight from the start, providing a sturdy foundation with a multitude of supportive resources to build momentum in the years ahead.”

The Wolpows have been deeply involved with Penn and Wharton for decades, making diverse contributions to various causes. They have strengthened creative programs at Penn through several initiatives, including the Kelly Writers House, the RealArts Internship Fund, the Creative Ventures Fund, and the Wolpow Family Support Fund. These programs provide support for Penn undergraduate student summer internships, projects, programs, and mentoring. Additionally, the Wolpows have established the Wolpow Family Endowed Scholarship for undergraduate students at Wharton and the Wolpow Family Faculty Scholar Award for junior faculty at the School. They are also loyal donors to The Wharton Fund and the Penn Fund, which provide important unrestricted funding for the School and University, respectively.

“We are delighted to provide foundational support to the Venture Lab and to partner with Wharton and Penn in creating an entrepreneurial ecosystem that spurs innovation in healthcare,” said Marc Wolpow. “Robin and I want to provide an enduring platform that catalyzes collaboration and allows budding entrepreneurs and students to push the boundaries of what is possible and bring their most audacious ideas to life. With this gift, Robin and I hope to provide opportunities and help support future leaders, as much as future businesses.”

Marc Wolpow is Co-Chief Executive Officer and Co-Founder of Audax Group, a leading alternative investment manager with offices in Boston, New York, San Francisco, and London. Marc and Robin launched AWF in 2022 and over the past year, the foundation has supported Boston Children’s Hospital, Memorial Sloan Kettering Cancer Center, The American Civil Liberties Union, and the Natural Resources Defense Council (NRDC), among other philanthropic organizations. Marc has extensive experience serving public organizations through prior memberships on the boards of trustees of Boston Children’s Hospital, Dartmouth Health, The Belmont Hill School, and The Park School. He is also an emeritus member of Wharton’s Undergraduate Executive Board.

Venture Lab, housed in one of the University’s newest buildings, Tangen Hall, is a partnership of the Wharton School, Penn Engineering, and the Stuart Weitzman School of Design. The program initially launched as Wharton Entrepreneurial Programs and evolved into Penn Wharton Entrepreneurship before being revamped as Venture Lab. Though Venture Lab is the newest incarnation, it has been the home of entrepreneurship on campus with a 50-year history.

Through Venture Lab and its former iterations, Wharton and Penn have supported many young entrepreneurs in dreaming up and starting their new business ideas, giving founders the knowledge, experience, and backing necessary to bring innovation to the world.

About the Wharton School

Founded in 1881 as the world’s first collegiate business school, the Wharton School of the University of Pennsylvania is shaping the future of business by incubating ideas, driving insights, and creating leaders who change the world. With a faculty of more than 235 renowned professors, Wharton has 5,000 undergraduate, MBA, executive MBA, and doctoral students. Each year 13,000 professionals from around the world advance their careers through Wharton Executive Education’s individual, company-customized, and online programs. More than 104,000 Wharton alumni form a powerful global network of leaders who transform business every day. For more information, visit http://www.wharton.upenn.edu.

About the University of Pennsylvania

The University of Pennsylvania, founded in 1740, is an Ivy League institution with a distinctive past. Its 12 undergraduate, graduate, and professional schools are located in Philadelphia on an attractive urban campus that serves a diverse community of more than 20,000 students from throughout the nation and around the world. Ranked consistently among the top universities in the nation, Penn has a longstanding reputation for excellence in graduate and professional education.

About The Arbour Way Foundation

The Arbour Way Foundation (“AWF”) was established in the spring of 2022 to support programs in health equity, educational opportunity, reproductive rights and environmental defense. Created by Audax Group Co-Founder Marc Wolpow and his wife Robin, AWF is positioned to be a value-added donor able to amplify the impact of its financial support through a collaborative “venture philanthropy” approach to giving.